Ionolyte

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate, the active ingredient in Ionolyte, is an electrolyte solution presented as an intravenous solution for IV use. It restores electrolyte balance and extracellular fluid volume in patients with depletion, hyponatremia, hypokalemia, or hypomagnesemia.

GNH USA supplies Ionolyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ionolyte is an intravenous electrolyte solution used to correct disturbances in body fluid and electrolyte composition.

- Electrolyte depletion: Replenishes magnesium, potassium, sodium and acetate ions to correct deficits. - Hyponatremia: Increases serum sodium concentration and improves osmolar balance. - Hypokalemia: Supplies potassium to raise low serum potassium levels. - Hypomagnesemia: Provides magnesium to normalize low magnesium concentrations. - Fluid replacement: Expands extracellular fluid volume in patients requiring volume resuscitation.

Ionolyte may be associated with adverse reactions following intravenous administration.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Transient hypernatremia: temporary rise in serum sodium. - Mild hypotension: slight drop in blood pressure during infusion. - Headache: occasional headache during or after infusion. - Nausea: mild nausea reported by some patients. - Flushing: brief skin flushing at the site.

Serious or Rare Side Effects: - Severe hyperkalemia: dangerous elevation of serum potassium. - Anaphylactic reaction: rare severe allergic response. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte shifts. - Severe hypermagnesemia: excessive magnesium leading to respiratory depression. - Metabolic acidosis: rare disturbance of acid‑base balance. - Thrombophlebitis: inflammation of the vein with clot formation.

Ionolyte requires careful clinical monitoring to avoid electrolyte‑related complications.

- Renal impairment: monitor electrolyte levels closely and adjust infusion rate. - Cardiac disease: assess baseline potassium and magnesium before administration. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concomitant diuretics: consider additional electrolyte loss and monitor labs. - Infusion rate: administer according to prescribed rate to prevent rapid shifts. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ionolyte can interact with other medicines that affect electrolyte balance or renal function.

Major Interactions (Avoid): - Calcium gluconate: may precipitate when mixed, causing line blockage. - Loop diuretics: additive loss of sodium, potassium and magnesium. - ACE inhibitors: increased risk of hyperkalemia. - Magnesium‑containing antacids: excess magnesium accumulation. - Blood transfusions: may alter electrolyte concentrations during massive transfusion.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal handling of electrolytes, requiring lab checks. - Beta‑blockers: monitor heart rate and rhythm when electrolyte shifts occur.